Natural & Alternative Remedies
-
Drotaverine tablets 40 mg 30 pcs Дротаверин таблетки по 40 мг 30 шт
Dosage form
Tablets №10 or №30.
Active ingredient
1 tablet contains drotaverinе hydrochloride 40 mg calculated as 100% substance.
Indications
Spasm of smooth muscles in visceral organs (cardio- and pyloric spasm), chronic gastroduodenitis, gastric and duodenal ulcers, cholelithiasis, nephrolithiasis (colics), chronic cholecystitis, postcholecystectomy syndrome, hypermotor biliary dyskinesia, spasmodic intestinal dyskinesia, intestinal colic associated with postoperative flatulence, colitis, proctitis, tenesmus, flatulence, pyelitis, headache associated with cerebral vasospasm, spasms of the coronary and peripheral arteries (obliterating endarteritis, Raynaud's disease), to weaken uterine contractions when needed and to relieve cervical spasm in labor, spasm of smooth muscles during instrumentation.
-
Escuvit film-coated tablets 40 mg 40 pcs Эскувит таблетки покрытые пленочной оболочкой по 40 мг 40 шт
Dosage form
Tablets №40.
Active INGREDIENT
1 tablet contains dry extract of horse chestnut fruit 40 mg.
Indications
Chronic venous insufficiency of various origins and its complications (swelling, cramping calf muscles, pain and feeling of heaviness in the legs, varicose veins, trophic changes, hemorrhoids), postthrombophlebitis syndrome, inflammatory and postoperative swelling of soft tissues.
-
Escuvit drops dropper bottle 25 ml Эскувит капли флакон-капельница 25 мл
Dosage form
Drops 25ml.
Active ingredient
100 g of the preparation contains: horse chestnut (Aesculus hippocastanum) fruit liquid extract - 10.0 g, thiamine chloride - 0.5 g; list of excipients: ethyl alcohol, purified water.
Indications
Chronic lower limb venous insufficiency due to varicose disease and postthrombophlebitic syndrome. Inflammatory-edematous changes in functional circulatory disturbances of the lower limbs and rectum; phlebitis, edema, haemorrhoids.
-
Calcium gluconate tablets 500 mg blister 10 pcs Кальция глюконат таблетки по 500 мг блистер 10 шт
Dosage form
Tablets №10.
Active ingredient
1 tablet contains 500 mg of calcium gluconate equivalent to 100% substance.
Indications
Diseases associated with hypocalcemia, increased cell membrane permeability, impaired transmission of nerve impulses in muscles. Hypoparathyroidism (latent tetany, osteoporosis), disturbances in vitamin D metabolism (rickets, spasmophilia, osteomalacia), hyperphosphatemia in patients with chronic renal failure. High calcium requirements (the period of intensive growth in children and adolescents, pregnancy, lactation), nutritional Ca2+ deficiency, disorders of calcium metabolism in postmenopausal period, bone fractures. Intensive loss of Ca2 + (long-term bedridden patients, chronic diarrhea, hypocalcemia, long-term administration of diuretics, antiepileptic drugs, corticosteroids). As a part of combined therapy of bleedings of varying genesis, allergic diseases (serum sickness, rash, fever syndrome, pruritus, itching dermatoses, angioneurotic edema); bronchial asthma, hunger edema, pulmonary tuberculosis, eclampsia, parenchymatous hepatitis, toxic liver damage, nephritis. Poisoning with magnesium salt, oxalic acid, soluble salts of fluoric acid (binding to calcium gluconate results in forming insoluble and non-toxic calcium oxalate and calcium fluoride).
-
Kasark tablets 16 mg 30 pcs Касарк таблетки по 16 мг 30 шт
DOSAGE FORM
Pills.
Main physicochemical properties:
Kasark®, tablets of 8 mg or 16 mg: tablets of white or almost white color, round shape, with a biconvex surface. Marbling is allowed on the surface of the tablet.
Kasark®, 32 mg tablets: white or almost white, round tablets with a biconvex surface, with a score on one side of the tablet. Marbling on the surface of the tablet is allowed.
COMPOSITION
active ingredient : candesartan cilexetil;
1 tablet contains candesartan cilexetil, calculated as 100% substance, 8 mg or 16 mg, or 32 mg;
excipients: carmellose calcium; corn starch; hydroxypropylcellulose; lactose monohydrate; magnesium stearate; polyethylene glycol (PEG 8000).
PHARMACOTHERAPEUTIC GROUP
Angiotensin II receptor antagonists.
ATX code C09C A06.
INDICATIONS FOR USE
Treatment of essential hypertension in adults.
Treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) as add-on therapy to ACE inhibitors or in cases of intolerance to ACE inhibitors.
-
Face and body cream KERASKIN for dry and sensitive skin moisturizing jar 400 ml Крем для лица и тела КЕРАСКИН для сухой и чувствительной кожи увлажняющий банка 400 мл
INDICATIONS FOR USE
Delicate cleansing and moisturizing for dry, sensitive and atopy-prone skin of adults and children from birth.
Moisturizes the skin for 48 hours.
Promotes nourishment, softening of the skin and rapid skin recovery in the presence of combing;
eliminates the feeling of tightness and discomfort caused by dryness;
Gently exfoliates dead skin cells.
How to use: apply KERASKIN cream with light massage movements at least 2 times a day (if necessary, you can use it more often). It can also be used in combination with products for restoring the skin's protective barrier - KERASKIN milk and facial and body skin cleansing - KERASKIN gel.
-
Clarithromycin film-coated tablets 250 mg blister 10 pcs Кларитромицин таблетки покрытые пленочной оболочкой по 250 мг блистер 10 шт
DOSAGE FORM
Film-coated tablets.
Main physicochemical properties: film-coated tablets, yellow in color, with a biconvex surface, with a score on one side of the tablet and embossing "KMP" on the other side. A white core is visible on the cross section.
COMPOSITION
active ingredient: clarithromycin;
1 tablet contains clarithromycin, calculated as 100% substance – 250 mg or 500 mg;
excipients: microcrystalline cellulose; sodium starch glycolate (type A); sodium lauryl sulfate; hypromellose; calcium stearate; coating mixture "Opadry II Yellow" (contains: triacetin; hypromellose; lactose, monohydrate; titanium dioxide (E 171); polyethylene glycol; iron oxide yellow (E 172)).
PHARMACOTHERAPEUTIC GROUP
Antimicrobials for systemic use. Macrolides. ATX code J01F A09.
INDICATIONS FOR USE
• Treatment of infections caused by microorganisms susceptible to clarithromycin:
• Upper respiratory tract infections, i.e. nasopharynx (tonsillitis, pharyngitis), and sinus infections.
• Lower respiratory tract infections (bronchitis, acute lobar pneumonia and primary atypical pneumonia) (see sections “Pharmacological properties.
• Pharmacodynamics” and “Special Instructions for Use” regarding susceptibility testing).
• Skin and soft tissue infections (impetigo, folliculitis, erysipeloid, furunculosis, infected wounds) (see sections “Pharmacological properties. Pharmacodynamics” and “Special instructions for use” for susceptibility testing).
• Acute and chronic odontogenic infections.
• Disseminated or localized mycobacterial infections caused by Mycobacterium avium or Mycobacterium intracellulare. Localized infections caused by Mycobacterium chelonae, Mycobacterium fortuitum or Mycobacterium kansasii.
• Eradication of H. pylori in patients with duodenal ulcer when suppressing hydrochloric acid secretion (clarithromycin activity against H. pylori at neutral pH is higher than at acidic pH).
-
Co-Prenelia tablets 4 mg/1.25 mg 30 pcs Ко-Пренелия таблетки 4 мг/1,25 мг 30 шт
Composition:
active ingredients : perindopril, indapamide.
1 tablet contains: perindopril tertbutylamine - 4 mg (corresponding to 3.338 mg of perindopril) and indapamide - 1.25 mg; or perindopril tertbutylamine - 8 mg (corresponding to 6.676 mg of perindopril) and indapamide - 2.5 mg;
Excipients: microcrystalline cellulose; lactose, monohydrate; colloidal anhydrous silicon dioxide; magnesium stearate.
Dosage form: Tablets.
Main physicochemical properties:
4 mg/1.25 mg tablets: white, oval tablets with a score on both sides and an embossed “+” image on each side of the score on one side of the tablet;
8 mg/2.5 mg tablets: white or almost white, round tablets with a score on one side.
Pharmacotherapeutic group: Combinations of angiotensin-converting enzyme (ACE) inhibitors. Perindopril and diuretics.
ATX code C09B A04.
Indication.
Treatment of essential hypertension.
-
Co-Prenelia tablets 8 mg/2.5 mg 30 pcs Ко-Пренелия таблетки 8 мг/2,5 мг мг 30 шт
COMPOSITION:
active ingredients : perindopril, indapamide.
1 tablet contains: perindopril tertbutylamine - 4 mg (corresponding to 3.338 mg of perindopril) and indapamide - 1.25 mg; or perindopril tertbutylamine - 8 mg (corresponding to 6.676 mg of perindopril) and indapamide - 2.5 mg;
Excipients: microcrystalline cellulose; lactose, monohydrate; colloidal anhydrous silicon dioxide; magnesium stearate.
PHARMACEUTICAL FORM. Tablets.
Main physicochemical properties:
4 mg/1.25 mg tablets: white, oval tablets with a score on both sides and an embossed “+” image on each side of the score on one side of the tablet;
8 mg/2.5 mg tablets: white or almost white, round tablets with a score on one side.
PHARMACOTHERAPEUTIC GROUP: Combinations of angiotensin-converting enzyme (ACE) inhibitors. Perindopril and diuretics.
ATX code C09B A04.
INDICATION.
Treatment of essential hypertension.
-
COPACYL tablets blister 10 pcs Копацил таблетки блистер 10 шт
DOSAGE FORM
Tablets №6 or №10.
ACTIVE INGREDIENT
1 tablet contains acetylsalicylic acid* – 300 mg, paracetamol* – 100 mg, caffeine* – 50 mg.
* equivalent to 100% of the substance
INDICATIONS
Mild or moderate pain syndrome (headache, arthralgia, migrane, toothache, neuralgia, primary dysmenorrhea). The drug can also be used as an antipyretic agent for diseases accompanied by fever.
-
Laritylen lozenges with mint and raspberry flavor 20 pcs Ларитилен таблетки для рассасывания со вкусом мяты и малины 20 шт
Dosage form
Lozenges.
Active ingredient
1 lozenge contains Dequalinium Chloride calculated to 100 % substance 0.25 mg, Dibucaine hydrochloride calculated to 100 % substance 0.03 mg.
Indications
Local treatment of acute painful inflammatory infections of mouth and throat: gingivitis, ulcerative and aphtous stomatitis, tonsillitis, laryngitis and pharyngitis. LARYTYLEN also recommended for treatment of bad breath. LARYTYLEN could be used in cases of mixed infections of mouth and pharynx (under doctor`s prescription); as adjuvant treatment in angina catarrhalis, angina lacunaris and Paul-Vincent’s angina; candidiasis of mouth or throat. It is recommended in postsurgical period after tonsillectomy and dental extractions.
-
Laritylen mint-flavored lozenges 20 pcs Ларитилен таблетки для рассасывания со вкусом мяты 20 шт
Dosage form
Lozenges.
Active ingredient
1 lozenge contains Dequalinium Chloride calculated to 100 % substance 0.25 mg, Dibucaine hydrochloride calculated to 100 % substance 0.03 mg.
Indications
Local treatment of acute painful inflammatory infections of mouth and throat: gingivitis, ulcerative and aphtous stomatitis, tonsillitis, laryngitis and pharyngitis. LARYTYLEN also recommended for treatment of bad breath. LARYTYLEN could be used in cases of mixed infections of mouth and pharynx (under doctor`s prescription); as adjuvant treatment in angina catarrhalis, angina lacunaris and Paul-Vincent’s angina; candidiasis of mouth or throat. It is recommended in postsurgical period after tonsillectomy and dental extractions.
-
Laritylen lozenges with mint and lemon flavor 20 pcs Ларитилен таблетки для рассасывания со вкусом мяты и лимона 20 шт
Dosage form
Lozenges.
Active ingredient
1 lozenge contains Dequalinium Chloride calculated to 100 % substance 0.25 mg, Dibucaine hydrochloride calculated to 100 % substance 0.03 mg.
Indications
Local treatment of acute painful inflammatory infections of mouth and throat: gingivitis, ulcerative and aphtous stomatitis, tonsillitis, laryngitis and pharyngitis. LARYTYLEN also recommended for treatment of bad breath. LARYTYLEN could be used in cases of mixed infections of mouth and pharynx (under doctor`s prescription); as adjuvant treatment in angina catarrhalis, angina lacunaris and Paul-Vincent’s angina; candidiasis of mouth or throat. It is recommended in postsurgical period after tonsillectomy and dental extractions.
-
Legkolax powder for oral solution in sachets of 4 g 10 pcs. Легколакс порошок для орального раствора в пакетах-саше по 4 г 10 шт
PHARMACEUTICAL FORM
Powder for oral solution.
Main physicochemical properties: white or almost white powder.
COMPOSITION
active ingredient: macrogol;
1 sachet contains polyethylene glycol (macrogol) 4000 in terms of 100% substance 4 g or 10 g.
1 can contains polyethylene glycol (macrogol) 4000 in terms of 100% substance 150 g or 300 g.
PHARMACOTHERAPEUTIC GROUP
Laxatives. Osmotic laxatives. Macrogol.
ATX code A06A D15.
INDICATIONS FOR USE
Symptomatic treatment of constipation.
